Overview
What is Biotechnology Innovation Organization?
The Biotechnology Innovation Organization (BIO) is a prominent nonprofit association based in Washington, D.C., representing approximately 1,000 member companies, academic institutions, patient groups, and related organizations from across the United States and over 30 countries. Founded on the belief that policy should foster innovation in the life sciences to address challenges in healthcare, agriculture, industry, and the environment, BIO's mission encompasses advocacy and policy efforts, as well as events and member services. With a workforce of 175 individuals, BIO advocates for its members' interests in various sectors, including healthcare, emerging companies, food and agriculture, and industrial and environmental issues. Their advocacy accomplishments include safeguarding intellectual property protections, advancing socially responsible biotechnology use, promoting investments in research, and improving the regulatory climate for biotech products. In the healthcare sector, they have advocated for policies recognizing innovation, safer regulatory environments, and greater patient access to therapies. They also advocate for biosimilars policies that protect patient safety and advance biomedical innovation. BIO's work extends to the international environment, where they have influenced improvements to the regulatory systems for ag-biotech products and supported farmers' rights to plant genetically engineered crops. Additionally, they have advocated for renewable chemicals and sustainably sourced biomass as eligible measures for emissions reduction credit generation.
Official website here: www.bio.org
Is Biotechnology Innovation Organization legitimate?
Biotechnology Innovation Organization is a legitimate nonprofit organization registered as a 501(c)(6) entity. Biotechnology Innovation Organization submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Heare are some key statistics you may want to consider:
Executive Compensation: $7,291,621
Professional Fundraising Fees: $0
Other Salaries and Wages: $20,702,321
For more financial information, click here
Official website here: www.bio.org
What is the mission statement of Biotechnology Innovation Organization?
The Biotechnology Innovation Organization (BIO) is a leading advocacy association with approximately 1,000 member companies and organizations in various sectors, including academia, research institutions, patient groups, and related organizations. Founded on the belief that innovation in the life sciences is essential to address challenges in healthcare, agriculture, industry, and the environment, BIO's mission is to nurture this innovation through policy advocacy and convening events. Their efforts cater to a wide spectrum of biotechnology applications across major sectors, with members representing a diverse range of industries and organizations. BIO's activities are organized into two programs: Advocacy and Services.
Official website here: www.bio.org
Who is the CEO of Biotechnology Innovation Organization?
Rachel King is the Principal Officer of Biotechnology Innovation Organization. The CEO's salary of Biotechnology Innovation Organization is $2,345,095 and their total compensation is $2,643,411.
Official website here: www.bio.org
What is the revenue of Biotechnology Innovation Organization?
Biotechnology Innovation Organization's revenue in 2022 was $103,185,175.
Official website here: www.bio.org
Who are the executives of Biotechnology Innovation Organization and what are their salaries?
The average compensation at Biotechnology Innovation Organization during 2022 was $159,965. There are 175 employees and 102 volunteers at Biotechnology Innovation Organization.
Here are 123 key members and their salaries (Biotechnology Innovation Organization's CEO's salary is $2,345,095 and their total compensation is $2,643,411):
- Compensation: $241,642
- Related: $0
- Other: $5,929
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $2,345,095
- Related: $0
- Other: $298,316
- Compensation: $658,466
- Related: $0
- Other: $66,647
- Compensation: $748,964
- Related: $0
- Other: $79,248
- Compensation: $747,313
- Related: $0
- Other: $71,539
- Compensation: $677,602
- Related: $0
- Other: $53,234
- Compensation: $610,444
- Related: $0
- Other: $81,585
- Compensation: $600,225
- Related: $0
- Other: $5,370
Official website here: www.bio.org
Where can I find the form 990 for Biotechnology Innovation Organization?
Biotechnology Innovation Organization's most recent form 990 was submitted in 2022 and can be accessed here.
Official website here: www.bio.org
Learn more at the official website: www.bio.org
Mission Statement of Biotechnology Innovation Organization
The Biotechnology Innovation Organization (BIO) is a significant advocacy association, representing around 1,000 member companies, academic and research institutions, patient groups, and related organizations from various sectors across the United States and more than 30 countries. Founded on the principle that policy should foster innovation in the life sciences to address challenges in healthcare, agriculture, industry, and the environment, BIO actively engages in advocacy and policy efforts.
BIO's mission revolves around nurturing innovation in the life sciences sector to overcome various hurdles. Its extensive membership base encompasses a diverse range of biotechnology applications, from healthcare to agriculture, industry, and the environment. The organizations and universities that make up BIO play essential roles in shaping the future of the life sciences. BIO's activities are divided into two primary programs: advocacy and services. Through advocacy, the organization lobbies for policies that promote innovation in the life sciences, ensuring a favorable regulatory landscape. The services program offers member benefits such as educational events, networking opportunities, and resources to help its members succeed and contribute to the advancement of the life sciences sector.
Shop smarter and support your favorite cause with the Give Freely browser extension. Save money with coupons and donate to charity with a single click. Download now!
Impact
October, 2024
The Biotechnology Innovation Organization (BIO) plays a critical role in shaping the biotechnology landscape through its advocacy and support for innovation across multiple sectors. With approximately 1,000 member companies, academic institutions, and patient groups, BIO fosters collaboration and dialogue that drives advancements in health care, agriculture, industrial applications, and environmental sustainability.
BIO's advocacy efforts are fundamental in promoting policies that enhance intellectual property protections, create favorable regulatory environments, and ensure patient access to innovative therapies. By engaging with lawmakers and international entities, BIO actively influences policies that support biomedical innovation, biosimilars, and safety standards for biotechnology products.
In the health sector, BIO effectively promotes policies that recognize the value of innovation, ensuring that new therapeutics and vaccines are accessible while safeguarding the rights of manufacturers. Their efforts to modernize clinical development paradigms and infrastructure bolster the biotechnology ecosystem, facilitating not just the creation of new solutions but also the sustainable growth of the industry.
For emerging companies, BIO advocates for supportive financial policies and works to reduce regulatory burdens, helping these organizations navigate the challenges of capital formation and innovation. In the agricultural sector, BIO champions the regulatory frameworks that empower farmers to utilize genetically engineered crops, essential for addressing global food security.
Additionally, BIO addresses environmental challenges through its support for sustainable practices and renewable resources, advocating for policies that treat sustainably sourced biomass favorably in emissions reduction contexts. Through these comprehensive advocacy efforts, BIO significantly influences the landscape of biotechnology, enhancing both innovation and public welfare.
This information is meant to be a general summary of Biotechnology Innovation Organization. Please take the time to review official sources before making any decisions based upon the content provided here.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2022.
- Investment Income: $3,416,988
- Program Service Revenue: $77,932,917
- Gross Receipts: $112,257,445
Assets and Liabilities:
- Total Assets: $124,412,600
- Total Liabilities: $73,648,403
- Net Assets: $50,764,197
Want to help this charity, for free? You can click here to learn more about Give Freely
Programs
Programs are reported by nonprofits in their tax forms and are normally their tax-exempt activities.
CONFERENCE / MEETING REVENUE
Revenue
$37,819,268
MEMBERSHIP DUES
Revenue
$36,288,173
SPECIAL INITIATIVES
Revenue
$2,609,145
CBI LOBBYING FUND
Revenue
$1,059,504
OTHER PROGRAM SERVICES
Revenue
$156,827
Organization Details
Founding Year
1981
Phone
(202) 962-9200Principal Officer
Rachel King
Main Address
1201 NEW YORK AVE NW NO 1300, WASHINGTON, DC, 20005
Website
www.bio.orgNTEE Category
Code: S40 - Community improvement
If you are a representative of Biotechnology Innovation Organization and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.